SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Walter Morton who wrote (901)11/5/1997 4:26:00 PM
From: Steve Harmon  Read Replies (1) | Respond to of 2742
 
Walter,

CIST is definitely not a earnings driven story. It is an EXTREME VALUE situation. CIST's current market valuation of $6 million is SILLY. Between CIST's cash position and IL-1 alone CIST's minimum value should be in the $36 million range and thats the absolute low.

The good news is that Bluestone Capital knows of this SILLY valuation and should be telling CISTRON's story to their clients shortly.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News